2020 ASTRO Annual Meeting

October 24-28, 2020

Max Credits: 201.5

Credit available 11/10/2020 - 11/15/2021

Activity Max Credits % Complete Status Earned Credits
EDU 03 Difficult Cases in Breast Cancer 1.25
Panel 02 A Roadmap for Recruiting Medical Students into Radiation Oncology during a Period of Waning Interest 1.25
PRO 03 Head and Neck Cancer: Case Based Discussion 1.25
International Session 01 Latin America ASTRO - Part 1 1.75
PRO 04 Gastrointestinal Cancer: Case Based Discussion 1.25
International Session 02 RUSSCO-ASTRO Joint Panel Session — Evidenced-based Management of Head and Neck Malignancies: Global Contexts and International Comparisons 1.25
PRO 01 Central Nervous System: Case Based Discussion 1.25
Joint Session 01 American Association for the Study of Liver Diseases (AASLD) — ASTRO Joint Session on the Multidisciplinary Management of Hepatocellular Carcinoma: Guidelines, Practicalities and a Tumor Board 1.25
EDU 02 Radiation/Immunotherapy Combinations in Localized Lung Cancer 1.25
PRO 05 Lung Cancer: A Case Based Discussion 1.25
EDU 01 Challenging Cases in Palliative Care 1.25
PRO 02 Lymphoma: Case Based Discussion 1.25
eContouring 01 eContouring for Lung Cancer 1.25
SS 02 Physics 01 - Best of Physics 1.25
SS 05 GU 02 - Salvage Radiotherapy and Systemic Therapy 1.25
SS 07 Biology 03 - Target Discovery 1.25
SS 03 Breast 01 - Techniques and Toxicities 1.25
SS 01 Biology 01 - Biology Special Session: Prediction and Monitoring of Radiation Response 1.25
SS 04 Biology 02 - Oncogenisis and Oncoprogression Signatures 1.25
QP 01 Digital Health Innovation/Informatics 1 - Clinical Applications of Artificial Intelligence Session 1 1
QP 02 GU 01 - Fractionation, Biology and Prognosis 1
QP 03 Education & Professional Development 01 1
QP 04 Pediatrics 01 - Focus on Pediatric Long Term Outcomes and Toxicity 1
SH 02 Science Highlights - Health Services Research/Global Oncology 0.5
SH 05 Science Highlights - (GU) Genitourinary 0.5
SH 01 Science Highlights - (CNS) Central Nervous System 0.5
SH 04 Science Highlights - Lung Cancer/Thoracic Malignancies 0.5
SH 06 Science Highlights - Radiation and Cancer Biology 0.5
SH 03 Science Highlights - Breast Cancer 0.5
SS 06 CNS 01 - Gliomas (Low Grade, High Grade) 1.25
Workshop 02 ACGME - Review Committee Update and Accreditation Info You Need for Your Program 1.25
ST 01 Storytelling 01 - Global and Domestic Prostate Cancer Disparities: Biology, Social Determinants, and Other Factors 1
CB 01 Cancer Breakthroughs 1 - Takeaways from the Major Oncology Meetings of 2020:  Featuring AACR and RRS 1
International Session 01 Latin America ASTRO - Part 2 1.5
SH 08 Science Highlights - Gynecological 0.5
SH 09 Science Highlights - (H&N) Head and Neck Cancers 0.5
SH 10 Science Highlights - Hematologic 0.5
SH 11 Science Highlights - Palliative Care 0.5
SH 12 Science Highlights - Patient Safety 0.5
SH 13 Science Highlights - Pediatric Cancer 0.5
SH 14 Science Highlights - Radiation and Cancer Physics 0.5
SH 15 Science Highlights - Sarcoma and Cutaneous Tumors 0.5
Panel 01 Quality Payment Program: RO Model and MIPS 2021 1.25
EDU 09 Controversies in Brain Metastasis Management: Interactive Case-Based Discussion 1.25
PRO 08 Prostate Cancer: Case Based Discussion 1.25
Panel 04 Evolving Treatment Paradigms for Locally Advanced Rectal Cancer: An ASTRO Evidence-Based Clinical Practice Guideline 1.25
PRO 07 ASTRO Scientific Review 2020 1.25
Panel 03 Global Management of Nasopharyngeal Carcinoma: Integrating Recent Data into Clinical Practice and Tackling Topics of Uncertainty 1.25
PRO 09 Gynecologic Cancer: Case Based Discussion 1.25
PRO 06 Socioeconomic Update 1.25
PRO 10 Breast Cancer: Case Based Discussion 1.25
EDU 06 High Yield Quality Assurance in Your Clinic: Keeping Clinic Safe for the Rest of Us 1.25
eContouring 02 eContouring for Oligometastatic Disease - Liver 1.25
SS 09 GU 03 - Novel Approaches to Genitourinary Malignancies 1.25
SS 10 Physics 03 - Special Session 1 - Artificial Intelligence in Radiomics and Outcome Predictions 1.25
SS 11 Palliative Care 01 - Improving the Quality of Palliative Radiotherapy 1.25
SS 14 Physics 04 - Special Session 2 - Artificial Intelligence for Imaging and Treatment Planning 1.25
SS 12 Pediatrics 02 - Maximizing Cure and Minimizing Toxicity for Pediatric Cancer 1.25
SS 13 Biology 04 - DNA Damage and Response 1.25
QP 05 Physics 02 - Practical Artificial Intelligence Applications for Patient Modeling, Treatment Planning, Image Guidance and Response Assessment 1
QP 06 Sarcoma and Extremity Skin Malignancies 1
QP 08 Lung 01 - Cardiac Effects of Radiotherapy 1
QP 09 Hematologic 1 - Survivorship: Improving the Benefit-Morbidity Balance of Radiotherapy in Hematologic Malignancies 1
PS 02 Presidential Symposium Segment II: Clinical Challenges and Potential Solutions 1
SS 08 Breast 02 - Biology and Outcomes 1.25
QP 07 HSR/Global Oncology 1 - Global Oncology and Health Disparities 1
Storytelling 03 COVID-19 Session 1.5
International Session 03 ASTRO/ESTRO Joint Session 1.25
Storytelling 02 A Stitch in Time Saves Nine 0.5
PS Introduction Presidential Symposium Introduction 0.5
PS 01 Presidential Symposium Segment I: Strategic initiatives 1
PS 03 Presidential Symposium Segment III: Partners and Collaborators 1
PS 04 Presidential Symposium Segment IV: A Practical Roadmap for Action 1
PS 05 Presidential Symposium Segment V: Summary and Conclusion 0.5
CB 02 Cancer Breakthroughs 2 - Takeaways from the Major Oncology Meetings of 2020: Featuring ESTRO 0.5
EDU 12 Patient Reported Outcomes: Incorporation into Your Work Flow 1.25
Special Session 03 Clinical Practice Guideline Highlight Session: Implementing New Recommendations 1.25
Joint Session 02 The Impact of Neoadjuvant Therapeutics on the Surgical, Medical Oncological, and Irradiation Approaches to Breast Cancer Treatment 1.25
EDU 08 Breast-Cancer Related Lymphedema: Risk Factors, Diagnosis and Management 1.25
EDU 17 Lung Cancer Difficult Cases: Thoracic Re-Treatment 1.25
EDU 07 Introduction to Big Data Analytics and Machine Learning 1.25
International Session 05 The Applicability of Hypofractionation for Breast, Prostate and Head and Neck Cancers: A Case-Based, Resource-Stratified Panel Discussion 1.25
International Session 04 IAEA - ASTRO Joint Session: Promises and Pitfalls of Proton Beam Therapy for New Adopters of Advanced Technology ? Global Perspectives 1.25
Panel 05 Mechanisms and Clinical Translation of FLASH-RT 1.25
Panel 06 AI Applications for Global Radiation Oncology 1.25
Panel 08 Genomics, Radiomics, and Radiogenomics for Lung Cancer Treatment Assessment in Radiation Therapy 1.25
Panel 07 New Patient-Focused Paradigms in Gynecologic Cancer 1.25
International Session 06 Chinese Refresher Course: Immunotherapy Beyond Anti-PD-1/L1 1.25
EDU 10 2021 Radiation Oncology Coding and Coverage Update 1.25
eContouring 03 eContouring for Head and Neck Cancer 1.25
SS 15 GI 01 1.25
PL 01 Plenary Session 1
SS 16 Biology 05 - Molecular Predictors of Prognosis and Response 1.25
SS 17 GYN 1 - Personalized Medicine in Gynecologic Cancers: Exploring Molecular Stratification and the Immune System 1.25
SS 18 Patient Safety 1.25
SS 21 Physics 06 - Imaging and Response Assessment 1.25
SS 23 Physics 07 - Delivery: Hardware Technologies and Novel Procedures 1.25
QP 12 GI 02 - Hypofractionation in GI Cancers 1
QP 10 HSR/Global Oncology 2 - Costs and Decisions 1
QP 11 Physics 05 - Imaging for Response Assessment and Outcome Analysis 1
QP 13 Breast 03 1
QP 14 Hematologic 2 - Integrating Radiotherapy in Curative Treatment for Hematologic Malignancies 1
Keynote Address I Keynote Address I - Closing the Cancer Divide AND Strengthening Health Systems: Interwoven Opportunities 1
SS 22 GU 04 - Prostate Dose, Volumes and Outcomes 1.25
ROI Luncheon ROI Session: Financial Planning: The SECURE Act and Its Impact on Your Future 1.25
CB 03 Cancer Breakthroughs 3 - Takeaways from the Major Oncology Meetings of 2020: Featuring ASCO and ASH 1
Panel 12 Indications of Medical Marijuana/Cannabinoids and Its Role in Cancer Therapy 1.25
Panel 11 German Radiation Oncology during National Socialism 1.25
Panel 14 Radiorecurrent and Metastatic Prostate Cancer: The Radiation Oncologist as the Quarterback 1.25
EDU 15 Stereotactic Radiotherapy in Management of Pediatric Malignancies 1.25
EDU 22 Underserved: The Urban/Rural Divide and Addressing Geographic Disparities in American Radiation Oncology 1.25
EDU 14 Combining Radiation and Immunotherapy for GU Malignancies: What Works, What Doesn't and What Next 1.25
Joint Session 03 The Intersection of Public Health and Radiation Oncology: What Radiation Oncologists Should Know About the FDA 1.25
EDU 16 Effectiveness, Cost, and Quality of Life in Lymphoma: Why RT Always Wins 1.25
EDU 21 Hypofractionation for Head and Neck Cancer 1.25
EDU 19 Glioblastoma Questions Asked and Answered: Case-based Tumor Board 1.25
Panel 13 Expanding the Indications for Radiation Therapy 1.25
Special Session 04 The Diverse Downstream Effects of Cytosolic DNA and dsRNA Sensing in Cancer 1.25
Special Session 02 ASTRO/NCI Diversity Symposium: Mitigating Implicit Bias in Radiation Oncology 1.25
Panel 09 Advancing Electronic Health Records Research in Radiation Oncology 1.25
Panel 15 Funding Your Research: Successful Strategies and Potential Pitfalls 1.25
EDU 13 Into the Heart! From Cardiac Avoidance to Treating the Heart: Insights from Malignancies to Arrhythmia 1.25
Panel 10 Peer Review Debate: Where Best To Invest? 1.25
eContouring 04 eContouring for Prostate Cancer 1.25
SS 28 Nursing and Supportive Care 1.25
SS 29 GI 03 - Biomarkers of Response in GI Cancers 1.25
SS 19 Late-breaking Special Session 1
SS 24 Patient Reported Outcomes/QoL/Survivorship - New Frontiers in Patient Reported Outcomes and Quality of Life 1.25
SS 25 Lung 02 - The Role of Radiotherapy in Oligometastasis/Stage IV Lung Cancer 1.25
SS 26 Biology 08 - Radiation Effects on Normal Tissue 1.25
SS 27 Physics 08 - Methodologies for Planning and Adaptation 1.25
SS 30 H&N 02 - Practical Head & Neck Radiotherapy 1.25
SS 31 Palliative Care 02 - From Palliation to Oligometastatic Disease: The Role of SBRT 1.25
SS 32 Biology 09 - Modulation of the Immune System and Tumor Microenvironment 1.25
QP 16 H&N 01 - Head & Neck in 2020 1
QP 19 Physics 09 - Motion Management 1
QP 20 Lung 03 - Novel Approaches to Non-small Cell Lung Cancer 1
QP 15 Biology 07 - Radiation and Immunotherapy 1
QP 18 Hematologic 3 - The Increasing Role of Radiotherapy in Relapsed/Refractory Disease and Palliation of Hematologic Malignancies 1
QP 17 Digital Health Innovation/Informatics 02 - Clinical Applications of Artificial Intelligence Session 2 1
Storytelling 04 Radiation Oncology in the Time of COVID 1.5
CB 04 Cancer Breakthroughs 4 - Takeaways from the Major Oncology Meetings of 2020: Featuring RSNA and AAPM 1
ST 04 Storytelling 04 - Overcoming Barriers to Radiation Oncology Access in Low-Resource Environments 1
SS 41 Late-breaking COVID-19 Scientific Session 1.25
Panel 19 Ethics and Big Data in Radiation Oncology 1.25
EDU 31 Immunology 101: Primer on Immunology, Mechanisms of Action of Immunotherapy, and Combinations with Radiation 1.25
Joint Session 04 Geriatric Oncology: What Do Radiation Oncologists Need to Know 1.25
EDU 29 Controversies in the Management of Adult Sarcomas 1.25
Panel 23 Daily Adaptive Planning Enables Ablative Radiation for Pancreatic Cancer 1.25
Panel 17 Lymphoma Crossing Borders ? Treatment Options Around the Globe 1.25
Panel 20 Breast Cancer in Women of African Heritage: Genetic and Socioeconomic Underpinnings of Health Disparities 1.25
EDU 28 Post-operative Management of Prostate Cancer 1.25
EDU 25 The Radiation Biology of Heavy Ion Radiation Therapy 1.25
EDU 24 Emerging and Re-emerging Topics in Brachytherapy 1.25
Workshop 06 Beyond Oligometastasis — Establishing and Implementing Metastatic Disease Program as a Distinct Specialty in Radiation Oncology 1.25
EDU 23 In Patients with a Long List of Previous Chemotherapy/Immunotherapy, How Safe Is It to Deliver Radiation? 1.25
Panel 22 Expanding Radiation Oncology Worldwide: A Review of Non-Profit Organization Initiatives and Panel Discussion on Opportunities for Engagement 1.25
EDU 04 Challenging Cases in Uterine Cancer 1.25
Panel 21 The Physics of FLASH Radiotherapy 1.25
EDU 26 Beyond TNM: Making Breast Radiotherapy Decisions Based on Tumor Biology  1.25
EDU 30 The Role of Stereotactic Radiotherapy in Renal Cell Carcinoma — Radioresistance or Resistance to Radiate? 1.25
Panel 18 Exosomes and Exosomal MicroRNAs in Radiation Therapy: Novel Assays for Treatment Personalization. 1.25
EDU 27 "Data Science for Dummies": A Step-By-Step Guide for Developing a Data Science Program 1.25
SS 33 Physics 10 - Planning: Algorithms and Optimization 1.25
SS 38 Biology 11 - Biologic Markers of Immune Response 1.25
SS 35 Physics 11 - Auto-segmentation and Imaging for Treatment Planning 1.25
SS 36 Lung 04 - Clinical Trials in Locally Advanced Non-small Cell Lung Cancer 1.25
SS 37 H&N 03 - Novel and Prospective Trials 1.25
QP 26 CNS 3 - Benign Tumors & Novel Biomarkers 1
QP 22 Pediatrics 03 - Changing the Paradigm for Pediatric Cancer Care 1
QP 21 CNS 2 - Brain Metastasis 1
QP 23 Biology 10 - Imaging and Normal Tissue Response 1
CT 01 Clinical Trials Session 1
QP 25 Physics 12 - Treatment Planning and Motion Management 1
SS 39 GYN 2 - Advancing the Therapeutic Ratio and Novel Therapies in Cervical Cancer 1.25
SS 40 Hematologic 4 - State-of-the-Art Image Guided Therapy in Lymphoma 1.25
SS 34 HSR/Global Oncology 3 - Healthcare Costs and Access to Care 1.25
Storytelling 06 ASTRO's COVID-19 Survey Results 1
Special Session 06 Special Session - COVID-19 and the Impact on the Healthcare Team 1